Piramal Pharma Solutions (PPS), the global contract manufacturing division of Piramal Pharma Ltd, is set to invest $80 million in expanding its sterile injectables facility in Lexington ...
MUMBAI, India, Sept. 30, 2024 /PRNewswire/ -- Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: ...
Piramal Pharma's company's revenue for the quarter under review stood at Rs 2,242 crore as compared to Rs 1,911 crore which implies an increase of 17 per cent Y-o-Y ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...
PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India ...
Piramal Pharma's tax expenses also rose threefold in the span of a year. In the previous fiscal cycle, the pharma company earmarked a total of Rs 19.03 crore for its tax expenses. Come September ...
Shares of Piramal Pharma Ltd surged 18.32 per cent after having opened strongly at ₹227.90 as against the previous closing of ₹216.70 on wednesday. The stock hit high of ₹260.00 and low of ...
Piramal Pharma Solutions (PPS) is set to invest $80 million in expanding its sterile injectables facility in Lexington, Kentucky, USA, projected for completion by FY27.
Piramal Pharma Limited is a global pharmaceutical company providing end-to-end pharma solutions to its customers and a portfolio of differentiated pharma and consumer products remaining anchored ...
Piramal Pharma Ltd share price was down by -4.21% from the previous closing price of ₹281.55. Who are peers of Piramal Pharma Ltd? The peers of Piramal Pharma Ltd are Sun Pharmaceuticals ...
PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India ...